91°µÍø

Scientists at the Department of Energy’s 91°µÍø recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.

Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology. 

A team from ORNL, joined by university students, recently traveled to the Ohio State University Research Reactor to conduct a novel experiment on nuclear thermal rocket fuel coatings — one that could help propel NASA’s astronauts to Mars faster and more efficiently. 

Jairus Hines, an electronics and unmanned systems technician at ORNL, works with airborne, waterborne and ground-based drones. As part of the lab’s Autonomous Systems group, he applies "low and slow" drone technology to radiation detection for national security missions.

During a recent visit to ORNL, several OASA (IE&E) representatives explored the ORNL’s leadership in advanced nuclear energy development to inform the design and construction of a microreactor to power mission-critical facilities at two Army bases. 

Professionals from government and industry gathered at ORNL for the Nondestructive Assay Holdup Measurements Training Course for Nuclear Criticality Safety, a hands-on training in nondestructive assay, a technique for detecting and quantifying holdup without disturbing operations. 

Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.

Scientists designing the world’s first controlled nuclear fusion power plant, ITER, needed to solve the problem of runaway electrons, negatively charged particles in the soup of matter in the plasma within the tokamak, the magnetic bottle intended to contain the massive energy produced. Simulations performed on Summit, the 200-petaflop supercomputer at ORNL, could offer the first step toward a solution.

Ryan Culler is the program manager at 91°µÍø, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care. 

ORNL’s annual workshop has become the premier forum for molten salt reactor, or MSR, collaboration and innovation, convening industry, academia and government experts to further advance MSR research and development. This year’s event attracted a record-breaking 365 participants from across the country, highlighting the momentum to bring MSRs online.